 |
Hadasit Bio-Holdings
Hadasit Bio-Holdings Ltd. (HBL) was founded and floated on the Tel Aviv Stock Exchange (TASE: HDST) in order to allow public participation in the promising field of biotechnology. It serves as a precedent in biotechnology financing - for the first time, public investment is allowed to participate in companies based on IP generated by Israel's foremost medical research center the Hadassah University Hospital (Hadassah). Investments Biotechnology Israel Life Sciences Early Stage companies ILSI Peptides small molecules
Hadasit Bio Holdings enables a diversified investment in Israeli biotech companies at stages ranging from start up with proof of concept in animals to companies with products and drugs in human clinical trials phase I and phase II. pharmaceutical drugs and treatments are being developed in the areas of cancer, tissue regeneration with stem cells and auto immune diseases, all fields where the Hadassah medical centers of research and innovation excel and have a world renowned name as leaders in the field.
Hbl.co.il ~
Site Info
Whois
Trace Route
RBL Check
|
 |
ISRAEL 60 PLUS
Israel, Israelfonds, Aktien, Werte, Börsenhandel, Israel 60 Plus, Investments, israelische Wirtschaft, High Tech, Pharma, Teva, Generika, Performance, TASE
Israelfonds.de ~
Site Info
Whois
Trace Route
RBL Check
|
|
|
|
Site Info
